Impact of the COVID-19 Pandemic on Solid Organ Transplant and Rejection Episodes in Brazil's Unified Healthcare System.

Brazil COVID-19 graft rejection organ transplant

Journal

Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588

Informations de publication

Date de publication:
06 Nov 2022
Historique:
received: 03 10 2022
revised: 28 10 2022
accepted: 28 10 2022
entrez: 11 11 2022
pubmed: 12 11 2022
medline: 12 11 2022
Statut: epublish

Résumé

Brazil has the world's largest public organ transplant program, which was severely affected by the COVID-19 pandemic. The primary aim of the study was to evaluate differences in solid organ transplants and rejection episodes during the COVID-19 pandemic compared to the five years before the pandemic in the country. A seven-year database was built by downloading data from the DATASUS server. The pandemic period was defined as March 2020 to December 2021. The pre-pandemic period was from January 2015 to March 2020. During the pandemic, the number of solid organ transplants decreased by 19.3% in 2020 and 22.6% in 2021 compared to 2019. We found a decrease for each evaluated organ, which was more pronounced for lung, pancreas, and kidney transplants. The seasonal plot of rejection data indicated a high rejection rate between 2018 and 2021. There was also an 18% (IRR 1.18 (95% CI 1.01 to 1.37), The total number of organ transplants performed in 2021 represents a setback of six years. Transplant procedures were concentrated in the Southeast region of the country, and a higher proportion of rejections occurred during the pandemic. Together, these findings could have an impact on transplant procedures and outcomes in Brazil.

Sections du résumé

BACKGROUND BACKGROUND
Brazil has the world's largest public organ transplant program, which was severely affected by the COVID-19 pandemic. The primary aim of the study was to evaluate differences in solid organ transplants and rejection episodes during the COVID-19 pandemic compared to the five years before the pandemic in the country.
METHODS METHODS
A seven-year database was built by downloading data from the DATASUS server. The pandemic period was defined as March 2020 to December 2021. The pre-pandemic period was from January 2015 to March 2020.
RESULTS RESULTS
During the pandemic, the number of solid organ transplants decreased by 19.3% in 2020 and 22.6% in 2021 compared to 2019. We found a decrease for each evaluated organ, which was more pronounced for lung, pancreas, and kidney transplants. The seasonal plot of rejection data indicated a high rejection rate between 2018 and 2021. There was also an 18% (IRR 1.18 (95% CI 1.01 to 1.37),
CONCLUSIONS CONCLUSIONS
The total number of organ transplants performed in 2021 represents a setback of six years. Transplant procedures were concentrated in the Southeast region of the country, and a higher proportion of rejections occurred during the pandemic. Together, these findings could have an impact on transplant procedures and outcomes in Brazil.

Identifiants

pubmed: 36362809
pii: jcm11216581
doi: 10.3390/jcm11216581
pmc: PMC9658443
pii:
doi:

Types de publication

Journal Article

Langues

eng

Références

PLoS One. 2021 Jul 28;16(7):e0254822
pubmed: 34320005
Transplantation. 2021 Jan 1;105(1):170-176
pubmed: 33093404
J Nephrol. 2022 Jan;35(1):367-369
pubmed: 34787799
Transpl Int. 2021 Dec;34(12):2899-2902
pubmed: 34555224
Transplantation. 2022 Jul 1;106(7):1312-1329
pubmed: 35404911
Rev Assoc Med Bras (1992). 2020 Jun;66(6):708-709
pubmed: 32696867
Lancet Reg Health Am. 2022 Jun;10:100222
pubmed: 35284904
Rev Col Bras Cir. 2021 Sep 24;48:e20213042
pubmed: 34586206
BMJ Open. 2021 Mar 16;11(3):e045343
pubmed: 33727273
Kidney360. 2021 Oct 07;2(12):2016-2018
pubmed: 35419543
J Bras Nefrol. 2022 Jul-Sep;44(3):428-433
pubmed: 34328168
Cad Saude Publica. 2019 Sep 16;35(9):e00032419
pubmed: 31531513
Kidney Int. 2020 Aug;98(2):513-514
pubmed: 32569652
Lancet. 2011 May 21;377(9779):1778-97
pubmed: 21561655
Lancet. 2019 Jul 27;394(10195):345-356
pubmed: 31303318
Lancet Public Health. 2021 Oct;6(10):e709-e719
pubmed: 34474014

Auteurs

Luis Gustavo Modelli de Andrade (LGM)

Department of Internal Medicine-UNESP, Univ Estadual Paulista, Av. Prof. Montenegro-Distrito de, Rubião Jr., s/n, Botucatu 18618-687, SP, Brazil.

Abner Macola Pacheco Barbosa (AMP)

Department of Internal Medicine-UNESP, Univ Estadual Paulista, Av. Prof. Montenegro-Distrito de, Rubião Jr., s/n, Botucatu 18618-687, SP, Brazil.

Naila Camila da Rocha (NC)

Department of Internal Medicine-UNESP, Univ Estadual Paulista, Av. Prof. Montenegro-Distrito de, Rubião Jr., s/n, Botucatu 18618-687, SP, Brazil.

Marilia Mastrocolla de Almeida Cardoso (MM)

Health Technology Assessment Center Hospital das Clínicas-HCFMB, Botucatu 18618-970, SP, Brazil.

Juliana Tereza Coneglian de Almeida (JTC)

Health Technology Assessment Center Hospital das Clínicas-HCFMB, Botucatu 18618-970, SP, Brazil.

Juliana Machado-Rugolo (J)

Health Technology Assessment Center Hospital das Clínicas-HCFMB, Botucatu 18618-970, SP, Brazil.

Lucas Frederico Arantes (LF)

Health Technology Assessment Center Hospital das Clínicas-HCFMB, Botucatu 18618-970, SP, Brazil.

Daniela Ferreira Salomão Pontes (DFS)

Department of Internal Medicine-UNESP, Univ Estadual Paulista, Av. Prof. Montenegro-Distrito de, Rubião Jr., s/n, Botucatu 18618-687, SP, Brazil.

Gustavo Fernandes Ferreira (GF)

Transplant Unit-Santa Casa Juiz de Fora, Av. Barão do Rio Branco, 3353-Passos, Juiz de Fora 36021-630, MG, Brazil.

Classifications MeSH